Coakley Christopher MD Plymouth, MA - 02360

Coakley Christopher MD is categorized under Internal Medicine Practitioners in Plymouth, MA and active since 1979.

Coakley Christopher MD was established in 1979, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Christopher Coakley at the company’s single location by writing to 45 Resnik Road # 303, Plymouth, Massachusetts MA 02360 or by phoning (508) 746-7858. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Coakley Christopher MD
Contact Person: Christopher Coakley
Address: 45 Resnik Road # 303, Plymouth, Massachusetts 02360
Phone Number: (508) 746-7858
Annual Revenue (USD): $500.000 to $999.999
Founded: 1979
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Coakley Christopher MD was started in 1979 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Christopher Coakley for inquiries that concern Coakley Christopher MD by calling the company number (508) 746-7858, as your correspondence is most welcome. Additionally, the physical location of the single location of Coakley Christopher MD can be found at the coordinates 41.95036,-70.70809 as well as the street address 45 Resnik Road # 303 in Plymouth, Massachusetts 02360.

For its online presence, you may visit Coakley Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.